LOC1720
Loc1720: A Novel Long Non-Coding RNA Involved in Cancer Pathogenesis
Description
Loc1720, also known as long non-coding RNA 1720, is a newly discovered lncRNA that has been found to play a significant role in cancer development and progression. LncRNAs are a class of non-coding RNAs that do not code for proteins but regulate gene expression at the transcriptional and post-transcriptional levels.
Loc1720 is located on chromosome 17q21.32 and consists of 1,720 nucleotides. It is known to be overexpressed in various types of cancer, including breast cancer, lung cancer, and colorectal cancer.
Associated Diseases
Overexpression of loc1720 has been linked to the development of several types of cancer, including:
- Breast cancer
- Lung cancer
- Colorectal cancer
- Gastric cancer
- Liver cancer
- Pancreatic cancer
Loc1720 has been shown to promote cancer cell proliferation, invasion, metastasis, and resistance to chemotherapy.
Did you Know ?
Studies have shown that elevated levels of loc1720 are associated with a worse prognosis in cancer patients. For instance, in patients with breast cancer, high loc1720 expression was found to be associated with a reduced overall survival rate.
